Ankur R. Chakravarthy
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Evolutionary dynamics of recurrent hepatocellular carcinoma under divergent immune selection pressures.
Journal: Frontiers in oncology
Published: November 29, 2024
Metabologenomic characterization uncovers a clinically aggressive IDH mutant glioma subtype.
Journal: Acta neuropathologica
Published: December 08, 2023
Ratio of stemness to interferon signalling as a biomarker and therapeutic target of myeloproliferative neoplasm progression to acute myeloid leukaemia.
Journal: British journal of haematology
Published: May 02, 2023
The chromatin and single-cell transcriptional landscapes of CD4 T cells in inflammatory bowel disease link risk loci with a proinflammatory Th17 cell population.
Journal: Frontiers in immunology
Published: February 08, 2023
H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 18, 2022
Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance.
Journal: Nature communications
Published: December 03, 2021
DNA methylation-based prognostic subtypes of chordoma tumors in tissue and plasma.
Journal: Neuro-oncology
Published: October 06, 2021
A clinically applicable integrative molecular classification of meningiomas.
Journal: Nature
Published: December 01, 2020
Author Correction: Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes.
Journal: Nature medicine
Published: September 08, 2020
An open-label, phase II multicohort study of an oral hypomethylating agent CC-486 and durvalumab in advanced solid tumors.
Journal: Journal for immunotherapy of cancer
Published: June 23, 2020
Last Updated: 09/26/2026